{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 3163,
  "pageSize": 60,
  "pageCount": 5333,
  "rows": [
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes a timeline of biopsy (Bx) and treatment, and paired dot plots showing pre/post treatment changes in CD68+ and CD3+ cell counts.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/18",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "3b7829c3-3966-42d3-a835-880f62f71399",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 12-20 present various traction metrics, including clinical trial results and partnerships",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Spider plot (swimmer plot variant) showing individual patient tumor response trajectories.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/19",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "3b7829c3-3966-42d3-a835-880f62f71399",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 12-20 present various traction metrics, including clinical trial results and partnerships",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": "The slide uses a two-part structure: a value proposition box followed by a list of upcoming milestones.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/20",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "3b7829c3-3966-42d3-a835-880f62f71399",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 12-20 present various traction metrics, including clinical trial results and partnerships",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/21",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a biological process diagram to illustrate the mechanism of action.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/22",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes statistical significance markers (*, **, ***) and TGI (Tumor Growth Inhibition) percentages.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/23",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/24",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": "The slide uses a three-pillar structure supported by a foundational platform.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/25",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "timeline",
      "function": "plan_implementation",
      "notes": "The slide uses a Gantt-style timeline to map clinical trial events (P2 data, FDA meetings, enrollment) against a calendar axis from 2021 to 2023.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/26",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "closing_ask",
      "function": "state_next_steps",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/27",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7a8f-7069-abd7-4f5a253312a5",
      "docSlug": "7534f8dddd85d538a9efc95a5aebf002",
      "documentTitle": "Aquestive Therapeutics | Results Presentation Deck | 14 slides",
      "authorId": "aquestive-therapeutics",
      "authorName": "Aquestive Therapeutics",
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.2938006,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": "https://imgproxy.kitesheet.com/YlN4K-yC5x-0IVI-c6rm2o44WS84f3ttsYXCsLKIYQI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83NTM0ZjhkZGRkODVkNTM4YTllZmM5NWE1YWViZjAwMi9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7a8f-7069-abd7-4f5a253312a5/1",
      "deckHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5",
      "deckAnchorHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/RqlYxOZP7u9EMC6sV0eFKMAMpBfasTCtECi2VmdDbs4/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83NTM0ZjhkZGRkODVkNTM4YTllZmM5NWE1YWViZjAwMi9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/uEpwWVVIy4leMu3ImVwbYsEhMEjs-skxjMFut2vIcX0/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83NTM0ZjhkZGRkODVkNTM4YTllZmM5NWE1YWViZjAwMi9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/JJ2A3ehgmnebGgwSgxdsHwMaYJS-y3-qsVA18oiwt-Q/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy83NTM0ZjhkZGRkODVkNTM4YTllZmM5NWE1YWViZjAwMi9wMDAxLnBuZw"
    },
    {
      "docId": "019de073-7a8f-7069-abd7-4f5a253312a5",
      "docSlug": "7534f8dddd85d538a9efc95a5aebf002",
      "documentTitle": "Aquestive Therapeutics | Results Presentation Deck | 14 slides",
      "authorId": "aquestive-therapeutics",
      "authorName": "Aquestive Therapeutics",
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.2938006,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7a8f-7069-abd7-4f5a253312a5/2",
      "deckHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5",
      "deckAnchorHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7a8f-7069-abd7-4f5a253312a5",
      "docSlug": "7534f8dddd85d538a9efc95a5aebf002",
      "documentTitle": "Aquestive Therapeutics | Results Presentation Deck | 14 slides",
      "authorId": "aquestive-therapeutics",
      "authorName": "Aquestive Therapeutics",
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.2938006,
      "pageNumber": 3,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": "Comparison of Tmax metrics and safety profiles for single vs repeat dosing.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7a8f-7069-abd7-4f5a253312a5/3",
      "deckHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5",
      "deckAnchorHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 3,
          "beatId": "fd64535f-8805-4be0-ab9c-f0396589752f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document provides relief through presentation of EPIPHAST II trial results, including key takeaways and data, on slides 3-13",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7a8f-7069-abd7-4f5a253312a5",
      "docSlug": "7534f8dddd85d538a9efc95a5aebf002",
      "documentTitle": "Aquestive Therapeutics | Results Presentation Deck | 14 slides",
      "authorId": "aquestive-therapeutics",
      "authorName": "Aquestive Therapeutics",
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.2938006,
      "pageNumber": 4,
      "slideType": "other",
      "function": "establish_context",
      "notes": "The slide uses callout boxes connected to specific organs to detail symptom frequency and clinical manifestations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7a8f-7069-abd7-4f5a253312a5/4",
      "deckHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5",
      "deckAnchorHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5#slide-4",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 4,
          "from": 4,
          "beatId": "c20935ec-3224-4765-b849-75a8a5dcbb5e",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "The document agitates the problem by presenting symptoms of anaphylactic shock on slide 4",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        },
        {
          "to": 13,
          "from": 3,
          "beatId": "fd64535f-8805-4be0-ab9c-f0396589752f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document provides relief through presentation of EPIPHAST II trial results, including key takeaways and data, on slides 3-13",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7a8f-7069-abd7-4f5a253312a5",
      "docSlug": "7534f8dddd85d538a9efc95a5aebf002",
      "documentTitle": "Aquestive Therapeutics | Results Presentation Deck | 14 slides",
      "authorId": "aquestive-therapeutics",
      "authorName": "Aquestive Therapeutics",
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.2938006,
      "pageNumber": 5,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "The chart uses a dual-line comparison to show the divergence in risk outcomes based on treatment timing.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7a8f-7069-abd7-4f5a253312a5/5",
      "deckHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5",
      "deckAnchorHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5#slide-5",
      "loopMatches": [
        {
          "to": 10,
          "from": 5,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "b6791be9-182b-48c3-8ddb-65cec4fe9e39",
          "evidence": "The document implies the cost of inaction through presentation of rapid epinephrine delivery and trial results",
          "position": 0,
          "objective": "What is the cost of not using Aquestive Therapeutics' epinephrine product?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 5,
          "beatId": "727c0be4-fcfe-4299-9b64-948e74df905f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "The document identifies the pain of anaphylactic shock and the need for rapid epinephrine delivery on slide 5",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 13,
          "from": 3,
          "beatId": "fd64535f-8805-4be0-ab9c-f0396589752f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document provides relief through presentation of EPIPHAST II trial results, including key takeaways and data, on slides 3-13",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7a8f-7069-abd7-4f5a253312a5",
      "docSlug": "7534f8dddd85d538a9efc95a5aebf002",
      "documentTitle": "Aquestive Therapeutics | Results Presentation Deck | 14 slides",
      "authorId": "aquestive-therapeutics",
      "authorName": "Aquestive Therapeutics",
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.2938006,
      "pageNumber": 6,
      "slideType": "other",
      "function": "establish_context",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7a8f-7069-abd7-4f5a253312a5/6",
      "deckHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5",
      "deckAnchorHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5#slide-6",
      "loopMatches": [
        {
          "to": 10,
          "from": 5,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "b6791be9-182b-48c3-8ddb-65cec4fe9e39",
          "evidence": "The document implies the cost of inaction through presentation of rapid epinephrine delivery and trial results",
          "position": 0,
          "objective": "What is the cost of not using Aquestive Therapeutics' epinephrine product?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 3,
          "beatId": "fd64535f-8805-4be0-ab9c-f0396589752f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document provides relief through presentation of EPIPHAST II trial results, including key takeaways and data, on slides 3-13",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7a8f-7069-abd7-4f5a253312a5",
      "docSlug": "7534f8dddd85d538a9efc95a5aebf002",
      "documentTitle": "Aquestive Therapeutics | Results Presentation Deck | 14 slides",
      "authorId": "aquestive-therapeutics",
      "authorName": "Aquestive Therapeutics",
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.2938006,
      "pageNumber": 7,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes box plot showing 10th/90th percentiles and line chart showing concentration over 20 minutes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7a8f-7069-abd7-4f5a253312a5/7",
      "deckHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5",
      "deckAnchorHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5#slide-7",
      "loopMatches": [
        {
          "to": 10,
          "from": 5,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "b6791be9-182b-48c3-8ddb-65cec4fe9e39",
          "evidence": "The document implies the cost of inaction through presentation of rapid epinephrine delivery and trial results",
          "position": 0,
          "objective": "What is the cost of not using Aquestive Therapeutics' epinephrine product?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 3,
          "beatId": "fd64535f-8805-4be0-ab9c-f0396589752f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document provides relief through presentation of EPIPHAST II trial results, including key takeaways and data, on slides 3-13",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7a8f-7069-abd7-4f5a253312a5",
      "docSlug": "7534f8dddd85d538a9efc95a5aebf002",
      "documentTitle": "Aquestive Therapeutics | Results Presentation Deck | 14 slides",
      "authorId": "aquestive-therapeutics",
      "authorName": "Aquestive Therapeutics",
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.2938006,
      "pageNumber": 8,
      "slideType": "key_takeaways",
      "function": "analyze_data",
      "notes": "Box plot showing baseline adjusted epinephrine Tmax.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7a8f-7069-abd7-4f5a253312a5/8",
      "deckHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5",
      "deckAnchorHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5#slide-8",
      "loopMatches": [
        {
          "to": 10,
          "from": 5,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "b6791be9-182b-48c3-8ddb-65cec4fe9e39",
          "evidence": "The document implies the cost of inaction through presentation of rapid epinephrine delivery and trial results",
          "position": 0,
          "objective": "What is the cost of not using Aquestive Therapeutics' epinephrine product?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 3,
          "beatId": "fd64535f-8805-4be0-ab9c-f0396589752f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document provides relief through presentation of EPIPHAST II trial results, including key takeaways and data, on slides 3-13",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7a8f-7069-abd7-4f5a253312a5",
      "docSlug": "7534f8dddd85d538a9efc95a5aebf002",
      "documentTitle": "Aquestive Therapeutics | Results Presentation Deck | 14 slides",
      "authorId": "aquestive-therapeutics",
      "authorName": "Aquestive Therapeutics",
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.2938006,
      "pageNumber": 9,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Shows rapid onset of therapeutic benefits for AQST-109.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7a8f-7069-abd7-4f5a253312a5/9",
      "deckHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5",
      "deckAnchorHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5#slide-9",
      "loopMatches": [
        {
          "to": 10,
          "from": 5,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "b6791be9-182b-48c3-8ddb-65cec4fe9e39",
          "evidence": "The document implies the cost of inaction through presentation of rapid epinephrine delivery and trial results",
          "position": 0,
          "objective": "What is the cost of not using Aquestive Therapeutics' epinephrine product?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 3,
          "beatId": "fd64535f-8805-4be0-ab9c-f0396589752f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document provides relief through presentation of EPIPHAST II trial results, including key takeaways and data, on slides 3-13",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7a8f-7069-abd7-4f5a253312a5",
      "docSlug": "7534f8dddd85d538a9efc95a5aebf002",
      "documentTitle": "Aquestive Therapeutics | Results Presentation Deck | 14 slides",
      "authorId": "aquestive-therapeutics",
      "authorName": "Aquestive Therapeutics",
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.2938006,
      "pageNumber": 10,
      "slideType": "key_takeaways",
      "function": "analyze_data",
      "notes": "Clinical trial data comparing sublingual/oral film (AQST-109) vs intramuscular injection.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7a8f-7069-abd7-4f5a253312a5/10",
      "deckHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5",
      "deckAnchorHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5#slide-10",
      "loopMatches": [
        {
          "to": 10,
          "from": 5,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "b6791be9-182b-48c3-8ddb-65cec4fe9e39",
          "evidence": "The document implies the cost of inaction through presentation of rapid epinephrine delivery and trial results",
          "position": 0,
          "objective": "What is the cost of not using Aquestive Therapeutics' epinephrine product?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 3,
          "beatId": "fd64535f-8805-4be0-ab9c-f0396589752f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document provides relief through presentation of EPIPHAST II trial results, including key takeaways and data, on slides 3-13",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7a8f-7069-abd7-4f5a253312a5",
      "docSlug": "7534f8dddd85d538a9efc95a5aebf002",
      "documentTitle": "Aquestive Therapeutics | Results Presentation Deck | 14 slides",
      "authorId": "aquestive-therapeutics",
      "authorName": "Aquestive Therapeutics",
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.2938006,
      "pageNumber": 11,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The chart shows box plots for baseline adjusted Epinephrine Cmax, highlighting differences in drug exposure between the two treatment groups.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7a8f-7069-abd7-4f5a253312a5/11",
      "deckHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5",
      "deckAnchorHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 3,
          "beatId": "fd64535f-8805-4be0-ab9c-f0396589752f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document provides relief through presentation of EPIPHAST II trial results, including key takeaways and data, on slides 3-13",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7a8f-7069-abd7-4f5a253312a5",
      "docSlug": "7534f8dddd85d538a9efc95a5aebf002",
      "documentTitle": "Aquestive Therapeutics | Results Presentation Deck | 14 slides",
      "authorId": "aquestive-therapeutics",
      "authorName": "Aquestive Therapeutics",
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.2938006,
      "pageNumber": 12,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7a8f-7069-abd7-4f5a253312a5/12",
      "deckHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5",
      "deckAnchorHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 3,
          "beatId": "fd64535f-8805-4be0-ab9c-f0396589752f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document provides relief through presentation of EPIPHAST II trial results, including key takeaways and data, on slides 3-13",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7a8f-7069-abd7-4f5a253312a5",
      "docSlug": "7534f8dddd85d538a9efc95a5aebf002",
      "documentTitle": "Aquestive Therapeutics | Results Presentation Deck | 14 slides",
      "authorId": "aquestive-therapeutics",
      "authorName": "Aquestive Therapeutics",
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.2938006,
      "pageNumber": 13,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7a8f-7069-abd7-4f5a253312a5/13",
      "deckHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5",
      "deckAnchorHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 13,
          "from": 3,
          "beatId": "fd64535f-8805-4be0-ab9c-f0396589752f",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "The document provides relief through presentation of EPIPHAST II trial results, including key takeaways and data, on slides 3-13",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7a8f-7069-abd7-4f5a253312a5",
      "docSlug": "7534f8dddd85d538a9efc95a5aebf002",
      "documentTitle": "Aquestive Therapeutics | Results Presentation Deck | 14 slides",
      "authorId": "aquestive-therapeutics",
      "authorName": "Aquestive Therapeutics",
      "documentKindSlug": "deck",
      "documentKindLabel": "Deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.2938006,
      "pageNumber": 14,
      "slideType": "closing_ask",
      "function": "state_next_steps",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7a8f-7069-abd7-4f5a253312a5/14",
      "deckHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5",
      "deckAnchorHref": "/decks/019de073-7a8f-7069-abd7-4f5a253312a5#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": "Includes company logo, ticker symbol, and a representative photo of a patient.",
      "imagePath": "https://imgproxy.kitesheet.com/Zzz11c1lelhUKzxkBJvo2A2kiiUqBRztN-_57wMg-UQ/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mOGIyNzg3OTkyZWIzMzc1NjIwZjc0MDU3NDQ3ZDBjOS9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/1",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/vb-2yMpyUXCWu5JFargPCCoh8-lsEp-siU5eZyR7rsg/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mOGIyNzg3OTkyZWIzMzc1NjIwZjc0MDU3NDQ3ZDBjOS9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/Hd8GdOh3aGLlwtIgJYiahS27qtuNHqGQT8yK8x_4qpA/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mOGIyNzg3OTkyZWIzMzc1NjIwZjc0MDU3NDQ3ZDBjOS9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/1M1bEc7C9qMOzFIGDOhf3kmwl8-GROSJX12p6gvVTv4/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9mOGIyNzg3OTkyZWIzMzc1NjIwZjc0MDU3NDQ3ZDBjOS9wMDAxLnBuZw"
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "appendix_disclosure",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/2",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "unfair_advantage",
      "function": "present_solution",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/3",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-3",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "The slide uses academic citations to establish the clinical relevance of the target protein.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/4",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-4",
      "loopMatches": [
        {
          "to": 6,
          "from": 4,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "2bad4849-76ce-484b-ad2f-532281679f0e",
          "evidence": "The document highlights the limitations of current treatments and the potential benefits of targeting GAS6/AXL signaling",
          "position": 0,
          "objective": "What is the cost of not addressing GAS6/AXL signaling in cancer treatment?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 4,
          "beatId": "28f3f743-e3cf-4d52-acd4-476055b1969c",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "Slides 4-6 highlight the problems associated with GAS6/AXL signaling and the need for effective treatment",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "Includes a scientific diagram of the signaling pathway and references to academic literature.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/5",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-5",
      "loopMatches": [
        {
          "to": 6,
          "from": 4,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "2bad4849-76ce-484b-ad2f-532281679f0e",
          "evidence": "The document highlights the limitations of current treatments and the potential benefits of targeting GAS6/AXL signaling",
          "position": 0,
          "objective": "What is the cost of not addressing GAS6/AXL signaling in cancer treatment?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 4,
          "beatId": "28f3f743-e3cf-4d52-acd4-476055b1969c",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "Slides 4-6 highlight the problems associated with GAS6/AXL signaling and the need for effective treatment",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "Includes a bifurcation diagram illustrating the relationship between SNAIL and ZEB mRNA levels in different cell phenotypes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/6",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-6",
      "loopMatches": [
        {
          "to": 6,
          "from": 4,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "2bad4849-76ce-484b-ad2f-532281679f0e",
          "evidence": "The document highlights the limitations of current treatments and the potential benefits of targeting GAS6/AXL signaling",
          "position": 0,
          "objective": "What is the cost of not addressing GAS6/AXL signaling in cancer treatment?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 4,
          "beatId": "28f3f743-e3cf-4d52-acd4-476055b1969c",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "Slides 4-6 highlight the problems associated with GAS6/AXL signaling and the need for effective treatment",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The slide uses a visual comparison of biological mechanisms to argue for the superiority of the company's 'Decoy AXL Receptor' approach.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/7",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-7",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 8,
          "from": 7,
          "beatId": "11724964-5613-4be9-bf42-0171a9076bf3",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "Slides 7-8 emphasize the limitations of current treatments and the potential benefits of Batiraxcept",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a two-column layout to contrast the drug's engineering/profile with its biomarker/IP strategy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/8",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-8",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 8,
          "from": 7,
          "beatId": "11724964-5613-4be9-bf42-0171a9076bf3",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "Slides 7-8 emphasize the limitations of current treatments and the potential benefits of Batiraxcept",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "team_bio",
      "function": "other",
      "notes": "The slide uses a standard organizational structure layout with headshots and a logo grid for credibility.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/9",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-9",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 9,
          "beatId": "c248cf41-19be-4f89-917f-152cb979aa75",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 9-11 present Batiraxcept as a potential solution, highlighting its mechanism of action and market opportunity",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a horizontal bar chart format to represent clinical trial stages for different drug combinations.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/10",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-10",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 9,
          "beatId": "c248cf41-19be-4f89-917f-152cb979aa75",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 9-11 present Batiraxcept as a potential solution, highlighting its mechanism of action and market opportunity",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The pie chart visualizes the relative size of the patient populations described in the list.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/11",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-11",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 9,
          "beatId": "c248cf41-19be-4f89-917f-152cb979aa75",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 9-11 present Batiraxcept as a potential solution, highlighting its mechanism of action and market opportunity",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/12",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-12",
      "loopMatches": [
        {
          "to": 15,
          "from": 12,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "ca889fd8-550d-4690-bdfd-ec18eba75312",
          "evidence": "The document presents promising results for Batiraxcept in PROC and highlights its potential for expansion into other indications",
          "position": 1,
          "objective": "Can Batiraxcept provide a quick win in PROC and a big bet for future growth?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a process flow diagram to show the Phase 1b study arms.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/13",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-13",
      "loopMatches": [
        {
          "to": 15,
          "from": 12,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "ca889fd8-550d-4690-bdfd-ec18eba75312",
          "evidence": "The document presents promising results for Batiraxcept in PROC and highlights its potential for expansion into other indications",
          "position": 1,
          "objective": "Can Batiraxcept provide a quick win in PROC and a big bet for future growth?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes specific clinical metrics (ORR, mPFS, mOS) comparing patients above and below the Minimal Efficacious Concentration (MEC).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/14",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-14",
      "loopMatches": [
        {
          "to": 15,
          "from": 12,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "ca889fd8-550d-4690-bdfd-ec18eba75312",
          "evidence": "The document presents promising results for Batiraxcept in PROC and highlights its potential for expansion into other indications",
          "position": 1,
          "objective": "Can Batiraxcept provide a quick win in PROC and a big bet for future growth?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The slide includes two scatter plots with error bars and two summary tables of experimental data.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/15",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-15",
      "loopMatches": [
        {
          "to": 15,
          "from": 12,
          "name": "Quick Win Big Bet",
          "slug": "47-quick-win-big-bet",
          "bestFor": "Transformation planning, 100-day plans, resource allocation",
          "matchId": "ca889fd8-550d-4690-bdfd-ec18eba75312",
          "evidence": "The document presents promising results for Batiraxcept in PROC and highlights its potential for expansion into other indications",
          "position": 1,
          "objective": "Can Batiraxcept provide a quick win in PROC and a big bet for future growth?",
          "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
          "confidence": 0.6,
          "description": "Separate initiatives into immediate wins and longer-term strategic bets"
        }
      ],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a swimmer plot (left) and a waterfall plot (right) to visualize clinical response.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/16",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide highlights clinical efficacy data from a Phase 1b trial (PROC).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/17",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "peer_benchmark",
      "function": "compare_peers",
      "notes": "The slide compares clinical outcomes (ORR, SD, CBR, PD) across four cohorts: two treatment groups and two historical control groups.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/18",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "Includes trial design diagram with randomization and endpoint hierarchy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/19",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "testimonial",
      "function": "show_traction",
      "notes": "The slide uses qualitative feedback from healthcare providers and KOLs to validate market demand.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/20",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-20",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "cover",
      "function": "front_matter",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/21",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-21",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "appendix_methodology",
      "function": "present_framework",
      "notes": "The slide uses a process flow diagram to illustrate the trial structure.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/22",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-22",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The slide includes detailed footnotes explaining specific adverse events and patient outcomes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/23",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-23",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes footnotes comparing results to historical METEOR and CANTATA studies.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/24",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-24",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data compares low vs high biomarker groups across different dosage cohorts.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/25",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "The slide outlines a clinical trial protocol including randomization, interim analysis for accelerated approval, and primary/secondary endpoints.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/26",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "testimonial",
      "function": "illustrate_case",
      "notes": "The slide uses a table to summarize key value propositions and speech bubbles to provide direct KOL validation.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/27",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "cover",
      "function": "front_matter",
      "notes": "The slide features a photo of a patient being comforted, emphasizing the human element of the medical treatment.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/28",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-28",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 29,
      "slideType": "appendix_methodology",
      "function": "plan_implementation",
      "notes": "The slide outlines a standard clinical trial schema with a dose-finding/safety phase followed by a randomized efficacy phase.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/29",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-29",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 30,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data cutoff date is August 18, 2022. N=21 patients.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/30",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-30",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 31,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes a footnote comparing results to a historical P3 study.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/31",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-31",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 32,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Swimmer plot showing patient IDs on y-axis and weeks on study on x-axis, with various clinical status markers.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/32",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-32",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 33,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Data shows a clear correlation between achieving MEC and better clinical outcomes in PDAC patients.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/33",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-33",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 34,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "PDAC stands for Pancreatic Ductal Adenocarcinoma. RP2D stands for Recommended Phase 2 Dose.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/34",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-34",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 35,
      "slideType": "why_now",
      "function": "argue_timing",
      "notes": "Includes qualitative feedback from KOLs and healthcare providers regarding clinical utility and patient selection.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/35",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-35",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7b6a-72bb-8d98-812d56d63617",
      "docSlug": "f8b2787992eb3375620f74057447d0c9",
      "documentTitle": "Aravive | Investor Presentation Deck | 39 slides",
      "authorId": "aravive",
      "authorName": "Aravive",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 36,
      "slideType": "timeline",
      "function": "plan_implementation",
      "notes": "The slide uses a horizontal timeline with four distinct time periods, each containing multiple clinical trial or regulatory events.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7b6a-72bb-8d98-812d56d63617/36",
      "deckHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617",
      "deckAnchorHref": "/decks/019de073-7b6a-72bb-8d98-812d56d63617#slide-36",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}